Effect of Severe Renal Impairment on the Safety, Tolerability, and Pharmacokinetics of AMG 986
Introduction: AMG 986 is a first-in-class, novel apelin receptor small molecule agonist initially developed for the treatment of heart failure
Read moreIntroduction: AMG 986 is a first-in-class, novel apelin receptor small molecule agonist initially developed for the treatment of heart failure
Read more